Larimar Therapeutics Inc’s: Contrasting Stock Performances in a Volatile Market

The market performance of Larimar Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $6.85 on 02/09/24, with the lowest value for the same timeframe being $2.18, recorded on 11/10/23.

52-week price history of LRMR Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Larimar Therapeutics Inc’s current trading price is 13.28% away from its 52-week high, while its distance from the 52-week low is 255.96%. The stock’s price range for this period has remained between $2.18 and $6.85. The Healthcare sector company’s shares managed to surpass a trading volume of around 160.6 for the day, which was noticeably higher compared to the shares’ average daily volume of 4.42 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Larimar Therapeutics Inc (LRMR) has experienced a quarterly rise of 178.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 340.74M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.94, with a change in price of +3.64. Similarly, Larimar Therapeutics Inc recorded 141,727 in trading volume during the last 100 days, posting a change of +88.35%.

LRMR Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LRMR stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.

LRMR Stock Stochastic Average

As of today, the raw stochastic average of Larimar Therapeutics Inc over the past 50 days is 99.35%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 99.19%. Additionally, the Stochastic %K and %D values for the company were 89.08% and 85.06%, respectively, over the past 20 days.

LRMR Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 70.55%. However, over the past six months, we’ve seen a weaker performance of 103.67%. The price of LRMR fallen by 68.70% over the last 30 days. And in the last five days, it has surged by 26.18%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts